Changes in population-level survival for advanced solid malignancies with new treatment options in the second decade of the 21st century.

08:00 EDT 16th May 2019 | BioPortfolio

Summary of "Changes in population-level survival for advanced solid malignancies with new treatment options in the second decade of the 21st century."

Several new treatments that improve survival in clinical trials have been developed for various solid malignancies in advanced stages. The effect of these options on survival in the general population is currently unknown.


Journal Details

This article was published in the following journal.

Name: Cancer
ISSN: 1097-0142


DeepDyve research library

PubMed Articles [24088 Associated PubMed Articles listed on BioPortfolio]

Prediction of survival with combining quantitative F-FDG PET/CT and DW-MRI parameters in sinonasal malignancies.

We aimed to establish the prognostic value of F-fluoro-deoxy-glucose positron emission/CT ( F-FDG PET/CT) and diffusion-weighted (DW) MRI in determining overall survival (OS), progression-free surviv...

Stage at diagnosis for childhood solid cancers in Australia: A population-based study.

Stage of cancer at diagnosis is one of the strongest predictors of survival and is essential for population cancer surveillance, comparison of cancer outcomes and to guide national cancer control stra...

Risk factors for death and survival in paraneoplastic pemphigus associated with hematologic malignancies in adults.

Paraneoplastic pemphigus (PNP) occurs more often in patients with hematologic malignancies (HMs) than in patients with solid cancer. Lung bronchiolitis obliterans (BO) is a severe complication of PNP.

Antibody-Drug Conjugates for the Therapy of Thoracic Malignancies.

Antibody-drug conjugates are a novel class of therapeutic agents incorporating both target-specific monoclonal antibodies and cytotoxic small molecules via a chemical linker. They were first introduce...

Hemato-oncology and palliative care teams: is it time for an integrated approach to patient care?

Integrated palliative care for those with advanced solid tumors yields significant benefits in patient and caregiver outcomes. However, most palliative care clinical trials have excluded patients with...

Clinical Trials [14573 Associated Clinical Trials listed on BioPortfolio]

A Phase I Study of MEDI9447 (Oleclumab) in Japanese Patients

This is a phase I, open-label study to assess the safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of MEDI9447 in Japanese patients with advanced solid malignanci...

Japanese Phase I Study of AZD2014 in Advanced Solid Malignancies

The primary objective of this study is to investigate the safety and tolerability of continuous and/or intermittent dosing of AZD2014 when given orally to patients with advanced solid mali...

Study of AZD8931 in Patients With Advanced Solid Malignancies

The main purpose of this study is to explore the safety and tolerability of multiple ascending doses (MAD) of AZD8931 in patients with advanced solid malignancies

A Study of TAK-659 in Adult Patients With Advanced Solid Tumor and Lymphoma Malignancies

This study is an open-label, multicenter, phase 1, dose escalation study of TAK-659 in adult patients with advanced solid tumor and lymphoma malignancies. This study will be the first to a...

Study of AZD9150 and MEDI4736 (Durvalumab) in Japanese Adult Patients With Advanced Solid Malignancies

This is a phase I, open-label study to assess the safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of AZD9150 monotherapy and AZD9150 in combination with durvalum...

Medical and Biotech [MESH] Definitions

A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.

Morphological or behavioral traits influenced by various living conditions that a population encounters especially as it pertains to REPRODUCTION and survival of the population (see POPULATION DYNAMICS) such as age at first reproductive event, number and size of offspring, and lifespan.

An alkylating agent of value against both hematologic malignancies and solid tumors.

Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy.

Evaluation of the level of physical, physiological, or mental functioning in the older population group.

Quick Search


DeepDyve research library

Relevant Topic

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Searches Linking to this Article